ISSN 2590-0048
Vol. 5, Issue 2-3, 2023April 18, 2023 CDT
Venetoclax: A New Partner in the Novel Treatment Era for Acute Myeloid Leukemia and Myelodysplastic Syndrome
Venetoclax: A New Partner in the Novel Treatment Era for Acute Myeloid Leukemia and Myelodysplastic Syndrome
Articles in Vol. 5, Issue 2-3, 2023
Vol. 5, Issue 2-3, 2023
- Racial Differences in Spinal Cord Compression Related Hospitalizations in Patients with Multiple MyelomaSamer Al HadidiDeepa DongarwarCarolina SchinkeSharmilan ThanendrarajanMaurizio ZangariJohn D. ShaughnessyFrits van Rhee
- Venetoclax: A New Partner in the Novel Treatment Era for Acute Myeloid Leukemia and Myelodysplastic SyndromeJean El‑CheikhGhassan BidaouiMustafa SaleNour MoukalledIman Abou DalleAli Bazarbachi
- Current Advances in Multiple Myeloma: A Post International Myeloma Society (IMS 2022) Round Table Debate by the International Academy for Clinical Hematology (IACH)Nizar J. Bahlis
1.
El‑Cheikh J, Bidaoui G, Sale M, Moukalled N, Abou Dalle I, Bazarbachi A. Venetoclax: A New Partner in the Novel Treatment Era for Acute Myeloid Leukemia and Myelodysplastic Syndrome. Clinical Hematology International. 2023;5(2-3). doi:10.1007/s44228-023-00041-x